Johnson & Johnson Pricing Innovative Medicine (JJIM) has finally released its annual transparency report. While the report was a bit tardy, it remains the most complete disclosure from any major manufacturer and offers unique insight into JJIM’s gross-to-net bubble.

Johnson & Johnson’s venture capital arm is leading an $85 million investment in HistoSonics ahead of the planned commercialization of its liver cancer treatment.

Holobiome has announced a research collaboration with Johnson & Johnson Innovation, focusing on the creation of novel microbiome therapeutics.

MeiraGTx Holdings plc (NASDAQ:MGTX) added $2.23 (17%) to $15.50 on Wednesday after the company raised $80 million in a private placement, which includes a $40 million equity investment from Johnson & Johnson Innovation - JJDC Inc.

A new collaboration between Johnson & Johnson Innovation and Veracyte, a genomic diagnostics company, will focus on the detection of lung cancer. The long-term agreement will be used to advance the development and commercialization of novel diagnostic tests to detect lung cancer at its earliest stages, when the disease is most treatable.

Aro Biotherapeutics Co. (Philadelphia, Pa.) unveiled the lead programs from its Centyrin pipeline Tuesday, along with a $13 million seed round from Johnson & Johnson Innovation - JJDC Inc. and BioMotiv LLC (Cleveland, Ohio).